Revive Therapeutics Ltd. (FRA:31R)

Revive Therapeutics Statistics

Total Valuation

FRA:31R has a market cap or net worth of EUR 2.66 million. The enterprise value is 2.69 million.

Market Cap	2.66M
Enterprise Value	2.69M

Important Dates

The next estimated earnings date is Thursday, February 26, 2026.

Earnings Date	Feb 26, 2026
Ex-Dividend Date	n/a

Share Statistics

Current Share Class	432.32M
Shares Outstanding	n/a
Shares Change (YoY)	+10.31%
Shares Change (QoQ)	+1.10%
Owned by Insiders (%)	1.46%
Owned by Institutions (%)	0.00%
Float	426.00M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	n/a
PB Ratio	-1.24
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-0.41
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 0.03

Current Ratio	0.03
Quick Ratio	0.01
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -664.21% and return on invested capital (ROIC) is -49.87%.

Return on Equity (ROE)	-664.21%
Return on Assets (ROA)	-16.11%
Return on Invested Capital (ROIC)	-49.87%
Return on Capital Employed (ROCE)	39.59%
Revenue Per Employee	n/a
Profits Per Employee	-3.31M
Employee Count	2
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

Beta (5Y)	n/a
52-Week Price Change	n/a
50-Day Moving Average	0.00
200-Day Moving Average	0.01
Relative Strength Index (RSI)	45.08
Average Volume (20 Days)	30,328

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

Revenue	n/a
Gross Profit	n/a
Operating Income	-812,086
Pretax Income	-6.62M
Net Income	-6.62M
EBITDA	-811,944
EBIT	-812,086
Earnings Per Share (EPS)	-0.02

Balance Sheet

The company has 12,820 in cash and 41,717 in debt, giving a net cash position of -28,897.

Cash & Cash Equivalents	12,820
Total Debt	41,717
Net Cash	-28,897
Net Cash Per Share	n/a
Equity (Book Value)	-2.14M
Book Value Per Share	-0.00
Working Capital	-2.13M

Cash Flow

Operating Cash Flow	-269,231
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

FRA:31R does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-10.31%
Shareholder Yield	-10.31%
Earnings Yield	-248.92%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1